Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma

Curr Eye Res. 2006 Mar;31(3):265-71. doi: 10.1080/02713680500545671.

Abstract

Purpose: Thy1 is a surface glycoprotein uniquely expressed in retinal ganglion cells (RGCs) in retina. The aim of this study was to investigate the expression change of Thy1 in a model of experimental glaucoma.

Methods: The change of protein and mRNA levels of Thy1 in the retina were studied using stereological counts of back-labeled RGCs, Western blot analysis, immunohistochemistry, and laser capture microdissection (LCM) of RGCs with quantitative PCR analysis of mRNA in a model of experimental glaucoma. LCM after optic nerve crush was also performed to evaluate Thy1 mRNA levels after a different injury.

Results: After 10 days of elevated IOP, there was a 34% loss of RGC number, Thy1 protein decreased 60% in eyes with elevated intraocular pressure (IOP), and Thy1 mRNA levels decreased 51% in RGCs. Both protein and mRNA level change of Thy1 is to a much greater extent than RGC number loss.

Conclusions: The current results confirm that Thy 1 mRNA levels do not reflect the number of RGCs present and extend this to include a parallel decrease in Thy1 protein levels. These results suggest that Thy1 serves as an early marker of RGC stress, but not a marker of RGC loss, in models of retinal damage.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Count
  • Disease Models, Animal
  • Down-Regulation
  • Glaucoma / metabolism*
  • Glaucoma / pathology
  • Immunohistochemistry
  • Intraocular Pressure
  • Male
  • RNA, Messenger / metabolism*
  • Rats
  • Rats, Inbred BN
  • Retinal Ganglion Cells / metabolism*
  • Retinal Ganglion Cells / pathology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thy-1 Antigens / genetics*
  • Thy-1 Antigens / metabolism

Substances

  • RNA, Messenger
  • Thy-1 Antigens